BRCA2 and cancer: PGD has been used to identify cancer predispositions in 22 common inherited cancer syndromes including breast cancer (BRCA1 and BRCA2), Gorlin syndrome, tuberous sclerosis, familial colorectal cancer, and retinoblastoma [6,7].